DADC
ATNM icon

D.A. Davidson & Co’s Actinium Pharmaceuticals ATNM Stock Holding History

D.A. Davidson & Co’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,650
Closed -$17K – 954
2020
Q2 		$17K Buy
1,650
+300
+22% +$2.27K ﹤0.01% 928
2020
Q1 		$8K Hold
1,350
– – ﹤0.01% 979
2019
Q4 		$9K Hold
1,350
– – ﹤0.01% 1004
2019
Q3 		$9K Hold
1,350
– – ﹤0.01% 1000
2019
Q2 		$10K Sell
1,350
-1,083
-45% -$10.9K ﹤0.01% 989
2019
Q1 		$35K Hold
2,433
– – ﹤0.01% 1128
2018
Q4 		$28K Hold
2,433
– – ﹤0.01% 1085
2018
Q3 		$54K Buy
2,433
+500
+26% +$10.2K ﹤0.01% 1148
2018
Q2 		$37K Hold
1,933
– – ﹤0.01% 1109
2018
Q1 		$21K Sell
1,933
-3,300
-63% -$56.1K ﹤0.01% 1095
2017
Q4 		$104K Buy
5,233
+3,633
+227% +$73.1K ﹤0.01% 1076
2017
Q3 		$27K Sell
1,600
-2,667
-63% -$58.5K ﹤0.01% 1073
2017
Q2 		$156K Hold
4,267
– – ﹤0.01% 1064
2017
Q1 		$193K Buy
4,267
+534
+14% +$20.5K ﹤0.01% 953
2016
Q4 		$98K Sell
3,733
-500
-12% -$15.6K ﹤0.01% 1311
2016
Q3 		$171K Buy
4,233
+1,233
+41% +$63.3K ﹤0.01% 1002
2016
Q2 		$159K Hold
3,000
– – ﹤0.01% 928
2016
Q1 		$179K Buy
3,000
+1,333
+80% +$84.2K 0.01% 883
2015
Q4 		$161K Buy
+1,667
New +$111K 0.01% 921

Other funds holding ATNM

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.A. Davidson & Co's ATNM Position: Q3 2020 in Review

D.A. Davidson & Co sold out of Actinium Pharmaceuticals (ATNM) in Q3 2020, closing a stake of 1,650 shares — an estimated $17K sold.

D.A. Davidson & Co first reported a position in ATNM in Q4 2015 and held it in 19 quarters. The position peaked at $193K in Q1 2017. 41 funds tracked by Wall St. Rank hold ATNM as of Q3 2020.

  • D.A. Davidson & Co reported no remaining Actinium Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,650 Actinium Pharmaceuticals shares in Q3 2020, an estimated $17K.
  • D.A. Davidson & Co first reported a position in Actinium Pharmaceuticals in Q4 2015 and held it in 19 quarters.
  • D.A. Davidson & Co's Actinium Pharmaceuticals position peaked at $193K in Q1 2017.
  • 41 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2020.

Based on D.A. Davidson & Co's 13F filing for Q3 2020, filed 2 Nov 2020.